Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2012 - MarketWatch (press release)

Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2012 - MarketWatch (press release) May 24th 2012, 20:10 Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2012 MarketWatch (press release) The resulting vaccine products, which are expected to deliver long-lasting, single-dose protection against infectious diseases in dogs and cats, will be advanced through veterinary studies in several indications by Immunovaccine's research partner.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Artikel Terkait